Company / R&D per Share
Collegium Pharmaceutical, Inc. R&D per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
-
FY2024
5-year range
$0.00 / $0.28
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#209 of 208
Health Care
What the data says
Declined from $0.12 to $0.00 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 208
▼
Key checks
Key Insights
- Peak r&d per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.12 | -58.1% |
| FY2021 | $0.28 | -0.5% |
| FY2020 | $0.28 | -9.2% |
| FY2019 | $0.31 | +17.6% |
| FY2018 | $0.26 | -2.7% |
| FY2017 | $0.27 | -62.3% |
| FY2016 | $0.72 | +22.4% |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026